Organisation of European
Cancer Institutes
Developing the future in
Comprehensive CanCer Care
Official OECI Journal
one more reason to Join the oeCi,
is CertifYing Your eXCellenCe
in onCologY!
Strategic priorities for the OECI
OECI OrganISatIOn Of EurOpEan CanCEr InStItutES
upda
ted
to O
ctob
er 2
015
OECI-EEIG Central Officec/o Fondation Universitaire11, Rue d’Egmont B-1000, Brussels, BelgiumPhone: +32 2 512 0146
oeCi BoarD
2015
PresidentDominique de ValeriolaBrussels, Belgium
OECI Central Office Guy StormeBrussels, Belgium
Past President Wim H. van Harten Amsterdam, The Netherlands
Executive Secretary Marco A. PierottiMilan, Italy
Treasurer José Maria Laranja Pontes Porto, Portugal
Elected MemberCarlos CaldasCambridge, United Kingdom
Elected MemberGunnar SaeterOslo, Norway
OECI DirectorSpecial Assistant to the PresidentClaudio Lombardo Genoa, Italy - Brussels, Belgium
Quality improvement in Oncologic Care and ResearchThe OECI is aiming to include more than 50% of its membership in the OECI Accreditation & Designation (A&D) Programme by the end of 2015 so to have a significant impact on the quality of cancer care in Europe. 22 OECI Members already received the OECI Accreditation and Designation certificate and many other cancer centres are in the process.Certified Institutes represent the so called “OECI Quality Programme and Network”.European UnionThe bottom-up approach of the A & D Programme contributes greatly to the OECI’s visibility vis à vis the EU and promotes the involvement of its Members in the Horizon 2020 and Health Programme, calls for applicationsOrganisational qualityIn order to strengthen the operational structure that facilitates translational research and integrated care, the OECI, as the European Network of Comprehensive and Clinical Cancer Centres and other cancer related bodies, promotes the improvement of organizational expertise. In addition to the A&D programme, the European Commission’s General Directorate for Health and Consumer Protection supports the establishment of a detailed and focused benchmarking of comprehensive cancer care to transfer best practices amongst OECI members, as well as disseminating them across the entire cancer community.Molecular Pathology and BiobanksIn view of the crucial role of pathology departments, and of the expected “influx” of new markers and diagnostics in a scope of “OMICS”, the OECI WG on Biobanks and Molecular Pathobiology acts in close cooperation with the EurocanPlatform, the European Association for Cancer Research, the BBMRI infrastructure, the European Society of Pathology and the IMPACTS network.Palliative careThe mandate of a comprehensive cancer centre is to prevent, cure and guarantee the best quality of life for all patients, independently of their prognosis. The development of a modern, palliative care approach that does not only focus on the last days/weeks of a patient’s life. A specific Working Group on Palliative Care has been launched in order to discuss an agreed mission for the “Palliative Care Unit”, with a specific focus on establishing common research and developing standards for palliative care provision. These initiatives are linked with the OECI’s A&D Programme and with the European Cancer Patients Coalition.Enhancing the partnership patients-cancer institutesThe OECI’s interest for issues concerning cancer patients is confirmed by the strategic alliance with the European Cancer Patient Coalition - ECPC, with whom the OECI agreed on specific initiatives to empower the involvement of patients. Bringing together patient organisations and cancer institutes, will provide a coherent picture of today’s cancer patients’ expectations, ranging from: quality of care to information on survivorship and medical nutrition, improvement in the quality of interdisciplinary patient treatment, harmonisation in oncology healthcare practices and patients’ advocacy capacity to effectively tackle cancer care inequalities in Europe.Education and TrainingEducational activities, focus, more particularly, on the above mentioned fields, and are flourishing in order to strengthen the OECI objectives and to disseminate the acquired knowledge. A special educational programme is jointly developed with the European Association for Cancer Research - EACR. The OECI is also involved in broadcasting the educational programme of the European School of Oncology ESO, which is a full member of the Organisation.Communication and DisseminationRegular updates of the Organisation are published on the website, which, together with e-cancermedicalscience (the official OECI e-journal), hosts cutting edge papers, news, reports and videos.
Working group anDaCtivities
Accreditation and Designation Mahasti SaghatchianParis, France
Biobanks and Molecular Pathobiology Giorgio StantaTrieste, Italy
Health Economics Wim H. van Harten Amsterdam, The Netherlands
EurocanPlatform Ulrik RingborgStockholm, Sweden
Palliative Care Massimo CostantiniReggio Emilia, Italy
START-OECI Lisa LicitraMilan, Italy
Communication and Dissemination Gordon McVie Milan, Italy Claudio LombardoGenoa, ItalyBrussels, Belgium
OECI OrganISatIOn Of EurOpEan CanCEr InStItutESOECI OrganISatIOn Of EurOpEan CanCEr InStItutESOECI OrganISatIOn Of EurOpEan CanCEr InStItutES
OECI Objectives
Dominique de Valeriola OECI President
Established in 1977 to promote greater cooperation among European cancer Institutes, in 2005 the network was remodelled into OECI-EEIG
“Organisation of European Cancer Institutes - European Economic Interest Grouping”.
Presently the OECI regroups 70 cancer centres and institutions across Europe.
Austria•Comprehensive Cancer Center Graz, Graz •Comprehensive Cancer Center Vienna, Wien •Zentrum für Tumorerkrankungen Linz
Onkologisches Leitspital für Oberösterreich, LinzBelgiumInstitut Jules Bordet (IJB), Brussels Kankercentrum Brussel, BrusselsAZ Groeninge, Kortrijk •Institut Roi Albert II, BrusselsCroatia•University Hospital for Tumors - University Hospital Centre Sestre Milosrdnice, ZagrebCzech RepublicMasarykuv onkologický ústav, Brno •Institut biostatistiky a analýz Lékarské a
Prírodovedecké fakulty Masarykovy university, Brno
Denmark•Kræftens Bekæmpelse Center for Kræftforskning, Copenhagen EstoniaSihtasutus Tartu Ülikooli Kliinikum, Tartu•North Estonia Medical Centre, Tallin FinlandHYKS Syöpäkeskus Helsinki University, HelsinkiFranceGustave Roussy, Villejuif Centre Leon Berard, Lyon•Institut Curie, Paris •Centre de Lutte Contre le Cancer Paul Strauss, Strasbourg •Centre Henri Becquerel, Rouen Germany•Deutsches Krebsforschungszentrum (DKFZ),
Heidelberg •Universitäts KrebsCentrum Dresden, Dresden•Charité Comprehensive Cancer Centre, BerlinHungaryOrszágos Onkológiai Intézet, Budapest •National Koranyi Institute of TB and Pulmonology, BudapestItalyCentro di Riferimento Oncologico, Istituto Nazionale Tumori, Aviano IRCCS Azienda Ospedaliera Universitaria San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro, GenovaIstituto Europeo di Oncologia, Milano
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, MilanoIstituto Nazionale Tumori Regina Elena, Roma Istituto Oncologico Veneto IRCCS-IOV, Padova Istituto Tumori Giovanni Paolo II, Istituto di Ricovero e Cura a Carattere Scientifico, BariIstituto Nazionale Tumori IRCCS “Fondazione G.Pascale” (INT-Pascale), Napoli IRCCS, Centro di Riferimento Oncologico della Basilicata (CROB), Rionero in VultureAzienda Ospedaliera Arcispedale S. Maria Nuova IRCCS, Reggio Emilia •Ospedale San Raffaele (OSR), Milano •European School of Oncology (ESO), Milano•IFOM - FIRC Institute of Molecular Oncology, Milano•Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori [IRST]-IRCCS, Meldola-Forlì •IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano •Ente Ospedaliero Ospedali Galliera, Genova•Nerviano Medical Sciences Group S.r.l., NervianoLithuania National Cancer Institute, Vilnus NorwayOslo Universitetssykehus (OUS), NorwayPoland•Wielkopolskie Centrum Onkologii, PoznanPortugalInstituto Português de Oncologia do Porto FG, EPE, Porto Instituto Português de Oncologia de Lisboa FG, EPE, Lisbon Instituto Português de Oncologia de Coimbra FG, EPE, Coimbra RomaniaThe “Prof. Dr. Ion Chiricuta” Institute of Oncology (IOCN), Cluj •SC RTC Radiology Therapeutic Center – Amethyst Radiotherapy, Otopeni Russia•Tatarstan Cancer Center “TCC”, Kazan•N.N. Blokhin Russian Cancer Research Centre, Moscow•P.A. Herzen Moscow Cancer Research Institute, Moscow
Serbia•Institute of Oncology (IOV) Sremska Kamenica
Novi Sad, Sremska Kamenica Slovakia•Ústav experimentálnej onkológie SAV, Bratislava Slovenia•Onkološki inštitut Ljubljana, LjubianaSpainFundación Instituto Valenciano de Oncología IVO Foundation, Valencia •Institut Català d’Oncologia, Barcelona•Instituto Madrileño de Oncología (Grupo IMO),
Madrid Sweden•Karolinska Institutet, Stockholm The NederlandNetherlands Cancer Institute, Amsterdam•Erasmus MC Kanker Instituut, Rotterdam•IKNL Integraal Kankercentrum Nederland, Utrecht•Maastricht University Medical Centre, Maastricht•Radboudumc Centrum voor Oncologie, Nijmegez
the OECI membership 2015
oeCi netWork 2015
OECI Members A&D certified OECI Members in the A&D process Other OECI Members Non - OECI Members in the A&D process
the OECI Quality network
“
“The OECI is a network of cancer Institutes aiming to improve the quality of cancer care and translational research in Europe also from an organisational viewpoint. Although physicians, nurses and researchers, constitute the core of cancer care and research, a smooth organisation, efficient logistics and state of the art complex infrastructure, are needed to accelerate the production and application of personalised care approaches.A coordination among cancer institutes at a European level can contribute to the production and dissemination of knowledge in order to reduce fragmentation and increase competitiveness with the ultimate goal to find new and better treatments, provide more comprehensive care and improve patients’ quality of life through an evidence-based medicine with a holistic approach.
Turkey•Dokuz Eylül Üniversitesi Onkoloji Enstitüsü, IzmirUkraine•RE Kavetsky Institute of Experimental Pathology, Oncology and
Radiobiology (IEPOR), KievUnited KingdomThe Christie NHS Foundation Trust, ManchesterCambridge Cancer Centre, CambridgeKing’s Health Partners Integrated Cancer Centre, London•Imperial College Healthcare NHS Trust, London
non-OECI Members in the a&D processVejle Cancer Hospital, DenmarkAnadolu Medical Centre, Kocaeli, TurkeyHumanitas Cancer Centre, Milan, Italy
